If you would like to write for this, or any other Emerald publication, then please use our Emerald for Authors service information about how to choose which publication to write for and submission guidelines are available for all. Please visit www.emeraldinsight.com/authors for more information.
About Emerald www.emeraldinsight.comEmerald is a global publisher linking research and practice to the benefit of society. The company manages a portfolio of more than 290 journals and over 2,350 books and book series volumes, as well as providing an extensive range of online products and additional customer resources and services.Emerald is both COUNTER 4 and TRANSFER compliant. The organization is a partner of the Committee on Publication Ethics (COPE) and also works with Portico and the LOCKSS initiative for digital archive preservation.
We examine whether stock market fully value intangible assets, especially R&D and Advertising expenses in a specific sample of firms: US net firms along eight years (1996 until 2003). We find that the market value-to-book increases when the return on equity is positive, but also rises as return on equity becomes more negative. We argue that the negative pricing is due the collision of large expenditures in R&D and Advertising that are subject to conservatism accounting practice. Our results are robust when compared with a sample of recent contemporaneous IPOs of US net firms. We are able to conclude that: i) investors look beyond aggregate earnings, ii) that investors value certain components of losses (R&D and Advertising expenditures) positively, iii) capital markets seem to give strong value to firms undertaking such investments, iv) and that the presence of growing R&D and Advertising expenditures, implies that the persistence of losses may have become a weaker indicator of likelihood of liquidation, v) when faced financial distressed, the mergers an acquisitions is the main strategy to exercise the growth option and maximize the value of the firm and vi) consequently analyse loss firms homogenous can lead incorrect specifications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.